CRISPR screen in regulatory T cells reveals modulators of Foxp3

Journal: Nature

Published: 2020-04-29

DOI: 10.1038/s41586-020-2246-4

Affiliations: 16

Authors: 25

Go to article
Institutions Share
Department of Pathology, NU, United States of America (USA) 0.20
UCSF Diabetes Center, United States of America (USA) 0.16
UCSF Department of Microbiology and Immunology, United States of America (USA) 0.13
Innovative Genomics Institute (IGI), United States of America (USA) 0.13
Plant Molecular and Cellular Biology Laboratory, Salk, United States of America (USA) 0.12
Robert H. Lurie Comprehensive Cancer Center, NU, United States of America (USA) 0.04
Division of Hematology and Oncology, NU, United States of America (USA) 0.04
College of Pharmacy, DMU, China 0.04
Department of Microbiology and Immunology, NU, United States of America (USA) 0.04
UCSF Sean N. Parker Autoimmune Research Laboratory, United States of America (USA) 0.03
UCSF Biomedical Sciences Program (BMS), United States of America (USA) 0.03
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.02
UCSF Helen Diller Family Comprehensive Cancer Center, United States of America (USA) 0.01
UCSF School of Medicine, United States of America (USA) 0.01
Chan Zuckerberg Biohub (CZ Biohub), United States of America (USA) 0.01
UCSF The Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER